• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孵化器在非洲有用吗?橡果科技与以企业家为中心的模式。

Can incubators work in Africa? Acorn Technologies and the entrepreneur-centric model.

机构信息

McLaughlin-Rotman Centre for Global Health, University Health Network and University of Toronto, 101 College Street Suite 406, Toronto ON, M5G 1L7, Canada.

出版信息

BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1(Suppl 1):S7. doi: 10.1186/1472-698X-10-S1-S7.

DOI:10.1186/1472-698X-10-S1-S7
PMID:21144078
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3001615/
Abstract

BACKGROUND

Incubators are organizations that support the growth of new and typically technology-based enterprises, by providing business support services that bring together human and financial capital. Although the traditional role of incubators has been for economic development, they may also be a useful policy lever to tackle global health, by fostering the development and delivery of local health innovation.Given its high disease burden, life sciences incubators hold particular potential for Africa. As the most industrially advanced African nation, South Africa serves as a litmus test for identifying effective incubator policies. The case study method was used to illustrate how one such publicly funded incubator founded in 2002, Acorn Technologies, helped to catalyze local health product innovation.

DISCUSSION

Acorn helped to support twelve biomedical device firms. One of them, Real World Diagnostics, was founded by a trainee from Acorn's innovative internship program (Hellfire). It developed rapid strip diagnostic tests for locally prevalent diseases including schistosomiasis and HIV, and reported $2 million (USD) in revenue in 2009.Acorn achieved this success by operating as a non-profit virtual incubator with little physical infrastructure. Employing a virtual model in combination with stringent selection criteria of capital efficiency for clients proved to be effective in reducing its own fixed costs. Acorn focused on entrepreneurship training and networking, both critical at an early stage in an environment dominated by multinational biomedical device companies.Acorn and its clients learned that employing a cross-subsidy business model allowed one to generate royalty revenue through imports to subsidize R&D for local diseases. However, funding constraints and government expectations for rapid self-sustainability forced Acorn to merge with its sister biotechnology incubator in 2009.

SUMMARY

A key to Acorn's achievements was identifying entrepreneurs with technologies with health and economic impact, and providing them with flexible support from an early stage. A virtual organizational model helped Acorn to focus on supporting entrepreneurs. Governments and funders may wish to consider incubation strategies that draw from these good practices. With the right policies and business models, incubators have the potential to generate both health and economic benefits for Africa.

摘要

背景

孵化器是通过提供汇集人力和财力的商业支持服务来支持新的、通常以技术为基础的企业成长的组织。虽然孵化器的传统角色一直是促进经济发展,但它们也可能通过促进当地卫生创新的发展和交付,成为解决全球卫生问题的一个有用的政策杠杆。鉴于其高疾病负担,生命科学孵化器对非洲具有特别大的潜力。作为非洲工业化程度最高的国家,南非是检验确定有效孵化器政策的试金石。本案例研究采用案例研究方法,说明了 2002 年成立的一家名为 Acorn Technologies 的此类公共资助孵化器如何帮助推动当地卫生产品创新。

讨论

Acorn 帮助支持了十二家生物医学设备公司。其中一家名为 Real World Diagnostics 的公司是由 Acorn 创新实习计划(Hellfire)的一名学员创立的。该公司开发了针对当地流行疾病(包括血吸虫病和 HIV)的快速条带诊断测试,并在 2009 年报告了 200 万美元的收入。Acorn 通过作为一个几乎没有物理基础设施的非营利性虚拟孵化器运作,实现了这一成功。事实证明,采用虚拟模式并结合对客户资本效率的严格选择标准,对于降低自身固定成本非常有效。Acorn 专注于创业培训和网络建设,这在跨国生物医学设备公司主导的环境中至关重要。Acorn 和它的客户了解到,采用交叉补贴商业模式可以通过进口来产生特许权使用费收入,以补贴针对当地疾病的研发。然而,资金限制和政府对快速实现自给自足的期望迫使 Acorn 于 2009 年与姊妹生物技术孵化器合并。

总结

Acorn 取得成功的关键是识别具有健康和经济影响的技术的企业家,并从早期为他们提供灵活的支持。虚拟组织模式有助于 Acorn 专注于支持企业家。政府和资助者可能希望考虑借鉴这些良好实践的孵化策略。通过正确的政策和商业模式,孵化器有可能为非洲带来健康和经济效益。

相似文献

1
Can incubators work in Africa? Acorn Technologies and the entrepreneur-centric model.孵化器在非洲有用吗?橡果科技与以企业家为中心的模式。
BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1(Suppl 1):S7. doi: 10.1186/1472-698X-10-S1-S7.
2
Business models for primary health care delivery in low- and middle-income countries: a scoping study of nine social entrepreneurs.低收入和中等收入国家初级卫生保健服务提供的商业模式:对九位社会企业家的范围界定研究
BMC Health Serv Res. 2021 Mar 9;21(1):211. doi: 10.1186/s12913-021-06225-6.
3
Venture capital on a shoestring: Bioventures' pioneering life sciences fund in South Africa.小资本风险投资:Bioventures 在南非开拓生命科学基金。
BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1(Suppl 1):S8. doi: 10.1186/1472-698X-10-S1-S8.
4
Physician entrepreneur: lessons learned in raising capital for biomedical innovation.医生型创业者:为生物医药创新融资的经验教训。
Curr Opin Anaesthesiol. 2010 Apr;23(2):209-17. doi: 10.1097/ACO.0b013e32833732fa.
5
Science-based health innovation in sub-Saharan Africa.撒哈拉以南非洲的基于科学的健康创新。
BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1(Suppl 1):S1. doi: 10.1186/1472-698X-10-S1-S1.
6
Senior Entrepreneurship: The Unrevealed Driver for Social Innovation.老年创业:社会创新的未被揭示的驱动力。
Front Sociol. 2019 Apr 24;4:30. doi: 10.3389/fsoc.2019.00030. eCollection 2019.
7
Venture funding for science-based African health innovation.基于科学的非洲健康创新的风险投资。
BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1(Suppl 1):S12. doi: 10.1186/1472-698X-10-S1-S12.
8
Networked incubators. Hothouses of the new economy.联网孵化器。新经济的温室。
Harv Bus Rev. 2000 Sep-Oct;78(5):74-84, 199.
9
Tuberculosis结核病
10
Science-based health innovation in Uganda: creative strategies for applying research to development.乌干达基于科学的健康创新:将研究应用于发展的创造性策略。
BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1(Suppl 1):S5. doi: 10.1186/1472-698X-10-S1-S5.

引用本文的文献

1
Mentoring, training and support to global health innovators: a scoping review.对全球卫生创新者的指导、培训与支持:一项范围综述
Glob J Health Sci. 2013 Jun 28;5(5):162-73. doi: 10.5539/gjhs.v5n5p162.
2
Venture capital on a shoestring: Bioventures' pioneering life sciences fund in South Africa.小资本风险投资:Bioventures 在南非开拓生命科学基金。
BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1(Suppl 1):S8. doi: 10.1186/1472-698X-10-S1-S8.

本文引用的文献

1
Small but tenacious: South Africa's health biotech sector.规模虽小但坚韧不拔:南非的健康生物技术行业。
Nat Biotechnol. 2009 May;27(5):427-45. doi: 10.1038/nbt0509-427.
2
South Africa: from species cradle to genomic applications.南非:从物种摇篮到基因组应用。
Nat Rev Genet. 2008 Oct;9 Suppl 1:S19-23. doi: 10.1038/nrg2441.
3
A tough transition.艰难的过渡。
Nature. 2007 Sep 13;449(7159):160-3. doi: 10.1038/449160a.
4
India's health biotech sector at a crossroads.印度健康生物技术行业正处于十字路口。
Nat Biotechnol. 2007 Apr;25(4):403-17. doi: 10.1038/nbt0407-403.
5
Sensitivity of commercial ethyl glucuronide (ETG) testing in screening for alcohol abstinence.商业性乙基葡萄糖醛酸苷(ETG)检测在筛查戒酒情况中的敏感性。
Alcohol Alcohol. 2007 Jul-Aug;42(4):317-20. doi: 10.1093/alcalc/agm014. Epub 2007 Mar 21.